Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer

Cell Biochemistry and Function

Volumn 25, Issue 4, 2007, Pages 419-422

  Zeybek, Umit ^a   Yaylim, Ilhan ^a   Yilmaz, Hulya ^a   Aǧaçhan, Bedia ^a   Ergen, Arzu ^a   Arikan, Soykan ^b   Bayrak, Savaş ^b   Isbir, Turgay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Education and Research Hospital   (Turkey)

Author keywords

Colorectal cancer; Gastric cancer; Methylenetetrahydrofolate reductase (MTHFR) gene polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CANCER; TURKEY (REPUBLIC);

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; TURKEY;

EID: 34447544092     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1317     Document Type: Article

References (26)

1. Bailey LB, Moyers S, Gregory JF. Folate. In Present Knowledge in Nutrition, Bowman BA, Russell RM (eds). International Life Sciences Institute: Washington, DC, 2001; pp 214-229.
2. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111-113.
3. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051.
4. Miao X, Xing D, Tan W, Qi J, Lu W, Lin D. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methyletetrahydrofolate reductase in an at risk Chinese population. Cancer Epidemiol Biomark Prev 2002; 11: 1454-1458.
5. Chen J, Giavannuci E, Kelsey K, et al. Methyletetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862-4864.
6. Ma J, Stampfer MJ, Giavannuci E, et al. Methyletetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 1997; 57: 1098-1102.
7. Gao C, Wu J, Ding J, et al. Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer (in Chinese) Zhanghua Liu Xing. Bing-Xue. Za Zhi, 2002; 23: 289-292.
8. Stolzenberg-Solomon RZ, You-Lin Qiao Y-L, Abnet CC, et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003; 12: 1222-1226.
9. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology 2001; 121: 282-301.
10. Jiang Q, Chen K, Ma X, et al. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev 2005; 29: 146-154.
11. Yin G, Kono S, Toyomura K, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2004; 95: 908-913.
12. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13: 285-292.
13. Toffoli G, Gafa R, Russo A, et al. Methylenetetrahydrofolate reductase 677 C → T polymorphism and risk of proximal colon cancer in north Italy. Clin Cancer Res 2003; 9: 743-748.
14. Keku T, Millikan R, Worley K, et al. 5,10- Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002; 11: 1611-1621.
15. Marugame T, Tsuji E, Kiyohara C, et al. Relation of plasma folate and methylenetetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol 2003; 32: 64-66.
16. Ulrich CM, Kampman E, Bigler J, et al. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol Biomarkers Prev 2000; 9: 27-33.
17. Kim DH, Ahn YO, Lee BH, Tsuji E, Kiyohara C, Kono S. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett. 2004; 216: 199-205.
18. Miller SA, Dykes DD, Polesky HS. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
19. Sharp L, Little C. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004; 159: 423-443.
20. Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 2000; 21: 461-467.
21. Foss HM, Roberts CJ, Claeys KM, Selker EU. Abnormal chromosome behavior in Neurospora mutants defective in DNA methylation. Science 1993; 262: 1737-1741.
22. Cravo M, Pinto R, Fidalgo P, et al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 1996; 39: 434-438.
23. Shen H, Xu Y, Zheng Y, et al. Polymorphisms of 5,10 methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 2001; 95: 332-336.
24. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000; 9: 849-853.
25. Ulvik A, Evensen ET, Lien EA, et al. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 2001; 101: 246-254.
26. Marugame T, Tsuji E, Kiyohara C, et al. Relation of plasma folate and methylenetetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol 2003; 32: 64-66.